These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19391310)

  • 1. Therapeutic monitoring of drug plasma concentrations and improved clinical outcomes in GIST.
    Demetri GD
    Clin Adv Hematol Oncol; 2009 Feb; 7(2):S6-7. PubMed ID: 19391310
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic monitoring of drug plasma concentrations and improved clinical outcomes in CML.
    Larson RA
    Clin Adv Hematol Oncol; 2009 Feb; 7(2):S3-5. PubMed ID: 19391309
    [No Abstract]   [Full Text] [Related]  

  • 3. Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors.
    Demetri GD; Wang Y; Wehrle E; Racine A; Nikolova Z; Blanke CD; Joensuu H; von Mehren M
    J Clin Oncol; 2009 Jul; 27(19):3141-7. PubMed ID: 19451435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Strategy for patients with GIST after failure of imatinib].
    Abe S; Kubota T
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):540-3. PubMed ID: 19381023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A step foward in the treatment of GIST].
    Fattoruso SI; Lopez M
    Clin Ter; 2008; 159(4):223-4. PubMed ID: 18776977
    [No Abstract]   [Full Text] [Related]  

  • 6. Gastrointestinal stromal tumor: a clinical overview.
    Quek R; George S
    Hematol Oncol Clin North Am; 2009 Feb; 23(1):69-78, viii. PubMed ID: 19248971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [GIST: our experience].
    Rossi MT; Fasano G; Morlino A; Scutari F
    G Chir; 2009; 30(1-2):41-5. PubMed ID: 19272232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successes and challenges in translational research: the development of targeted therapy for gastrointestinal stromal tumours.
    Renouf DJ; Wilson L; Blanke CD
    Clin Cancer Res; 2009 Jun; 15(12):3908-11. PubMed ID: 19509180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective neoadjuvant therapy prior to metastasectomy: a new paradigm.
    Schulick RD
    Ann Surg; 2007 Mar; 245(3):353-4. PubMed ID: 17435540
    [No Abstract]   [Full Text] [Related]  

  • 10. Imatinib for patients with liver or kidney dysfunction: no need to modify the dose.
    Judson IR
    J Clin Oncol; 2008 Feb; 26(4):521-2. PubMed ID: 18235112
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastrointestinal stromal tumors II: medical oncology and tumor response assessment.
    Benjamin RS; Debiec-Rychter M; Le Cesne A; Sleijfer S; Demetri GD; Joensuu H; Schöffski P; Poveda A
    Semin Oncol; 2009 Aug; 36(4):302-11. PubMed ID: 19664491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastrointestinal stromal tumour: our experience].
    Versaci A; Macrì A; Ieni A; Terranova M; Leonello G; Saladino E; Speciale G; Famulari C
    Chir Ital; 2009; 61(2):161-9. PubMed ID: 19536989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib in gastrointestinal stromal tumor: does treatment duration matter?
    Adenis A; Penel N; Blay JY
    Oncology; 2009; 77(3-4):157-61. PubMed ID: 19729974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical treatment of an advanced GIST the age of imatinib].
    Fernández JA; Parrilla P
    Cir Esp; 2009 Jul; 86(1):3-12. PubMed ID: 19539273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST.
    Pitini V; Arrigo C; Sauta MG; Altavilla G
    Leuk Res; 2009 Sep; 33(9):e143-4. PubMed ID: 19443031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Small-molecule inhibitors against KIT and PDGFRs especially in GISTs].
    Shiba K; Matsumoto T; Hirota S
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1080-5. PubMed ID: 19620796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular side effects associated with imatinib mesylate and perifosine for gastrointestinal stromal tumor.
    Dogan SS; Esmaeli B
    Hematol Oncol Clin North Am; 2009 Feb; 23(1):109-14, ix. PubMed ID: 19248974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between trough imatinib plasma concentration and clinical response in chronic myeloid leukemia.
    Mahon FX; Molimard M
    Leuk Res; 2009 Aug; 33(8):1147-8; author reply 1149-50. PubMed ID: 19395027
    [No Abstract]   [Full Text] [Related]  

  • 19. [An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors].
    Lang A; Graeven U
    Zentralbl Chir; 2009 Jun; 134(3):189-92. PubMed ID: 19544236
    [No Abstract]   [Full Text] [Related]  

  • 20. Promises and pitfalls of oral cancer chemotherapy.
    Ergolin MJ
    Clin Adv Hematol Oncol; 2009 Feb; 7(2):S8-10. PubMed ID: 19391311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.